Aerovate Therapeutics, Inc.

Q3 2023 13F Holders

Symbol
AVTE
CUSIP
008064107
Type
Equity
Class
COM
Num filings
60
Total reported value, excl. options
$386 M
Manager Report Date Value ($000) Shares Option Type